Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase

American Journal of Physiology - Cell Physiology

Volumn 301, Issue 2, 2011, Pages

  Wallace, Breanna K ^a   Foroutan, Shahin ^a   O'Donnell, Martha E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier; Bumetanide; Cerebral edema; Stroke

Indexed keywords

ARGIPRESSIN; BUMETANIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; RUBIDIUM 86; SODIUM POTASSIUM CHLORIDE COTRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; CEREBRAL MICROVASCULAR ENDOTHELIAL CELL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOXIA; IMMUNOFLUORESCENCE TEST; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ADENYLATE KINASE; ANIMALS; ARGININE VASOPRESSIN; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BUMETANIDE; CATTLE; CELL HYPOXIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICROVESSELS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; TIME FACTORS; UP-REGULATION;

RATTUS;

EID: 79961007564     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00517.2010     Document Type: Article

References (53)

1. Betz AL. Alterations in cerebral endothelial cell function in ischemia. Adv Neurol 71: 301-313, 1996.
2. Betz AL, Keep RF, Beer ME, Ren XD. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab 14: 29-37, 1994.
3. Bourke RS, Kimelberg HK, Nelson LR, Barron KD, Auen EL, Popp AJ, Waldman JB. Biology of glial swelling in experimental brain edema. Adv Neurol Brain Edema 28: 99-109, 1980.
4. Brillault J, Lam TI, Rutkowsky JM, Foroutan S, O'Donnell ME. Hypoxia effects on cell volume and ion uptake of cerebral microvascular endothelial cells. Am J Physiol Cell Physiol 294: C88-C96, 2008.
5. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med 333: 1392-1400, 1995.
6. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 29: 18-24, 2004.
7. Chen YJ, Anderson SE, O'Donnell ME. Bumetanide and HOE642 administered after initiation of middle cerebral artery occlusion effectively reduce rat brain Na uptake and infarct. FASEB J 23: A614.A613, 2009.
8. Chen YJ, Lam TI, Anderson SE, Walton JH, O'Donnell ME. Bloodbrain barrier Na-K-Cl cotransporter and Na/H exchanger: therapeutic targets for ischemia-induced brain Na uptake and edema formation. J Cereb Blood Flow Metab 29: S489, 2009.
9. Davis BJ, Xie Z, Viollet B, Zou MH. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 55: 496-505, 2006.
10. Ennis SR, Ren XD, Betz AL. Mechanisms of sodium transport at the blood-brain barrier studied with in situ perfusion of rat brain. J Neurochem 66: 756-763, 1996.
11. Fisslthaler B, Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 105: 114-127, 2009.
12. - cotransporter. Am J Physiol Cell Physiol 289: C1492-C1501, 2005
13. Fraser SA, Gimenez I, Cook N, Jennings I, Katerelos M, Katsis F, Levidiotis V, Kemp BE, Power DA. Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J 405: 85-93, 2007.
14. Frederich M, Zhang L, Balschi JA. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart. Am J Physiol Heart Circ Physiol 288: H2412-H2421, 2005.
15. Fryer LGD, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
16. Golshani P, Liu XB, Jones EG. Differences in quantal amplitude reflect GluR4- subunit number at corticothalamic synapses on two populations of thalamic neurons. Proc Natl Acad Sci USA 98: 4172-4177, 2001.
17. Gotoh O, Asano T, Koide T, Takakura K. Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I. The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin. Stroke 16: 101-109, 1985.
18. Hallows KR, Kobinger GP, Wilson JM, Witters LA, Foskett JK. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 284: C1297- C11308, 2003.
19. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487, 2004.
20. Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183, 2003.
21. Hatashita S, Hoff JT. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke 21: 582-588, 1990.
22. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887, 1996.
23. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066, 2005.
24. Iadecola C. Mechanisms of cerebral ischemic damage. In: Cerebral Ischemia: Molecular and Cellular Pathophysiology, edited by Walz W. Totowa, NJ: Humana, 1999, p. 3-34.
25. Jing M, Ismail-Beigi F. Critical role of 5=-AMP-activated protein kinase in the stimulation of glucose transport in response to inhibition of oxidative phosphorylation. Am J Physiol Cell Physiol 292: C477-C487, 2007.
26. Keep RF. Potassium transport at the blood-brain and blood-CSF barriers. In: Frontiers in Cerebral Vascular Biology: Transport and Its Regulation, edited by Drewes LR and Betz AL. New York: Plenum, 1993, p. 43-54.
27. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, van Denderen B, Jennings IG, Iseli T, Michell BJ, Witters LA. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168, 2003.
28. Kimelberg HK. Cell Swelling in Cerebral Ischemia. In: Cerebral Ischemia: Molecular and Cellular Pathophysiology, edited by Walz W. Totowa, NJ: Humana, 1999, p. 45-68.
29. Kimelberg HK. Current concepts of brain edema. Review of laboratory investigations. J Neurosurg 83: 1051-1059, 1995.
30. Klein H, Garneau L, Trinh NT, Prive A, Dionne F, Goupil E, Thuringer D, Parent L, Brochiero E, Sauve R. Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells. Am J Physiol Cell Physiol 296: C285-C295, 2009.
31. Lam TI, Wise PM, O'Donnell ME. Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin. Am J Physiol Cell Physiol 297: C278-C289, 2009.
32. Lee M, Hwang JT, Lee HJ, Jung SN, Kang I, Chi SG, Kim SS, Ha J. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 278: 39653-39661, 2003.
33. Li J, McCullough LD. Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 30: 480-492, 2010.
34. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 38: 2992-299
35. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280: 20493-204502, 2005.
36. Menzies SA, Betz AL, Hoff JT. Contributions of ions and albumin to the formation and resolution of ischemic brain edema. J Neurosurg 78: 257-266, 1993
37. Nakatsu Y, Kotake Y, Hino A, Ohta S. Activation of AMP-activated protein kinase by tributyltin induces neuronal cell death. Toxicol Appl Pharmacol 230: 358-363, 2008.
38. Menzies SA, Hoff JT, Betz AL. Extravasation of albumin in ischaemic brain oedema. Acta Neurochir (Wien) 51: 220-222, 1990.
39. O'Donnell ME. Regulation of Na-K-Cl cotransport in endothelial cells by atrial natriuretic factor. Am J Physiol Cell Physiol 257: C36-C44, 1989.
40. O'Donnell ME, Duong V, Suvatne J, Foroutan S, Johnson DM. Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent. Am J Physiol Cell Physiol 289: C283-C292, 2005.
41. O'Donnell ME, Martinez A, Sun D. Cerebral microvascular endothelial cell Na-K-Cl cotransport: regulation by astrocyte-conditioned medium. Am J Physiol Cell Physiol 268: C747-C754, 1995.
42. O'Donnell ME, Martinez A, Sun D. Endothelial Na-K-Cl cotransport regulation by tonicity and hormones: phosphorylation of cotransport protein. Am J Physiol Cell Physiol 269: C1513-C1523, 1995.
43. O'Donnell ME, Tran L, Lam TI, Liu XB, Anderson SE. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab 24: 1046-1056, 2004.
44. + exchanger by the AMP-activated protein kinase. Biochem Biophys Res Commun 398: 677-682, 2010.
45. Schielke GP, Moises HC, Betz AL. Blood to brain sodium transport and interstitial fluid potassium concentration during focal ischemia in the rat. J Cereb Blood Flow Metab 11: 466-471, 1991.
46. Sun D, Lytle C, O'Donnell ME. Astroglial cell-induced expression of Na-K-Cl cotransporter in brain microvascular endothelial cells. Am J Physiol Cell Physiol 269: C1506-C1512, 1995.9, 2007.
47. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 72: 1707-1716, 1999.
48. Wallace BK, Jelks KA, Foroutan S, O'Donnell ME. Ischemia-induced stimulation of the BBB Na-K-Cl cotransporter: evidence for a role of p38 MAP kinase. FASEB J 22: A734.734, 2008.
49. Wallace BK, O'Donnell ME. Ischemic factor activation of p38, JNK and ERK1/2 MAP kinases in cerebral microvascular endothelial cells. 2009 Society for Neuroscience Meeting Planner, Chicago IL: Society for Neuroscience 2009: Program No. 148.110 2009.
50. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2: 21-33, 2005.
51. Woods A, Vertommen D, Neumann D, Turk R, Bayliss J, Schlattner U, Wallimann T, Carling D, Rider MH. Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis. J Biol Chem 278: 28434-28442, 2003.
52. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirschman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.
53. Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH, Cohen RA. Activation of 5=-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. J Biol Chem 278: 34003-34010, 2003